| Literature DB >> 30374157 |
D R Gutleb1,2,3, J Ostner4,5,6, O Schülke4,5,6, W Wajjwalku7, M Sukmak7, C Roos8,9, A Noll9.
Abstract
We designed a genotyping panel for the investigation of the genetic underpinnings of inter-individual differences in aggression and the physiological stress response. The panel builds on single nucleotide polymorphisms (SNPs) in genes involved in the three subsystems of the hypothalamic-pituitary-adrenal (HPA)-axis: the catecholamine, serotonin and corticoid metabolism. To promote the pipeline for use with wild animal populations, we used non-invasively collected faecal samples from a wild population of Assamese macaques (Macaca assamensis). We targeted loci of 46 previously reported SNPs in 21 candidate genes coding for elements of the HPA-axis and amplified and sequenced them using next-generation Illumina sequencing technology. We compared multiple bioinformatics pipelines for variant calling and variant effect prediction. Based on this strategy and the application of different quality thresholds, we identified up to 159 SNPs with different types of predicted functional effects among our natural study population. This study provides a massively parallel sequencing panel that will facilitate integrating large-scale SNP data into behavioural and physiological studies. Such a multi-faceted approach will promote understanding of flexibility and constraints of animal behaviour and hormone physiology.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30374157 PMCID: PMC6206064 DOI: 10.1038/s41598-018-34223-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
List of all genes included in the multi-locus genotyping panel.
| HGNC gene symbol | Name | Information |
|---|---|---|
| AVPR1B | arginine vasopressin receptor 1B | • present in the brain as well as in the pituitary where it stimulates ACTH release |
| BDNF | brain-derived neurotrophic factor | • associated with stress vulnerability |
| COMT | catechol-O-methyl transferase | • degrades catecholamines such as dopamine, epinephrine and norepinephrine |
| CRH | corticotropin-releasing hormone | • plays a crucial role in the behavioural and neuroendocrine stress response |
| CRHBP | corticotropin releasing hormone binding protein | • this high-affinity protein regulates CRH availability |
| CRHR1 | corticotropin-releasing hormone receptor 1 | • binds CRH |
| CRHR2 | corticotropin-releasing hormone receptor 2 | • binds CRH in the membranes of hormone-sensitive cells |
| DRD3 | dopamine receptor D3 | • expressed in phylogenetically old regions of the brain |
| FKBP5 | FK506 binding protein 5 | • is a co-chaperone of the glucocorticoid receptor |
| HTR1A | serotonin receptor 1A | • binds serotonin |
| HTR1B | serotonin receptor 1B | • widely expressed in the central nervous system |
| MAOA | monoamine oxidase A | • breaks down serotonin, melatonin, noradrenaline and adrenaline |
| MC2R | ACTH receptor | • binding of ACTH stimulates cortisol production |
| NPY | neuropeptide Y | • most abundant neuropeptide in the mammalian brain and affects its activity |
| NR3C1 | glucocorticoid receptor | • cortisol and other glucocorticoids bind to this receptor |
| OPRM1 | opioid receptor mu 1 | • high affinity for enkephalins and beta-endorphin |
| OXTR | oxytocin receptor | • presence in central nervous system |
| SERPINA6 | corticosteroid binding globulin | • binding and transport of glucocorticoids in mammals |
| SLC6A3 | dopamine transporter | • actively removes neurotransmitters from the synaptic cleft |
| SLC6A4 | serotonin transporter | • regulates the serotonin re-uptake in the synaptic cleft |
| TPH2 | tryptophan hydroxylase 2 | • it is the rate-limiting enzyme in the synthesis of serotonin |
Note: For more details about the target regions, including chromosomal position, SNPs, functional consequences and selected references see Supplementary Table S1.
General descriptive statisics of the detected SNPs in the investigated population of Assamese macaques.
| Individuals | In percentage | In the number of individuals | ||||||
|---|---|---|---|---|---|---|---|---|
| Minimun | Maximum | Mean | Standard deviation | Minimun | Maximum | Mean | Standard deviation | |
| homozygous for reference allele | 0.00 | 98.73 | 82.60 | 28.00 | 0.00 | 78.00 | 62.65 | 22.88 |
| heterozygous | 0.00 | 56.96 | 10.28 | 15.29 | 0.00 | 45.00 | 7.83 | 11.82 |
| homozygous for alternate allele | 0.00 | 100.00 | 7.12 | 20.10 | 0.00 | 78.00 | 4.28 | 11.43 |
Count and percent of consequence types of SNPs predicted by VEP and SnpEff.
| Consequence type | VEP | SnpEff | ||
|---|---|---|---|---|
| Count | Percent | Count | Percent | |
| 3_prime_UTR_variant | 13 | 2.36% | 13 | 2.23% |
| 5_prime_UTR_premature_ start_codon_gain_variant | 0 | 0% | 2 | 0.34% |
| 5_prime_UTR_variant | 6 | 1.09% | 6 | 1.03% |
| downstream_gene_variant | 20 | 3.62% | 20 | 3.44% |
| frameshift_variant | 0 | 0.00% | 0 | 0.00% |
| intergenic_variant | 11 | 1.99% | 39 | 6.70% |
| intron_variant | 260 | 47.10% | 260 | 44.67% |
| missense_variant | 62 | 11.23% | 62 | 10.65% |
| splice_region_variant | 19 | 3.44% | 19 | 3.26% |
| synonymous_variant | 105 | 19.02% | 105 | 18.04% |
| upstream_gene_variant | 56 | 10.14% | 56 | 9.62% |
| total | 552 | 100.00% | 582 | 100.00% |
Count and percent of impact classes of SNPs predicted by VEP and SnpEff.
| Consequence type | VEP | SnpEff | ||
|---|---|---|---|---|
| Count | Percent | Count | Percent | |
| moderate | 122 | 22.89% | 124 | 22.03% |
| low | 62 | 11.63% | 62 | 11.01% |
| modifier | 349 | 65.48% | 377 | 66.96% |
| total | 533 | 100% | 563 | 100.00% |